liver fibrosis

Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis
Fierce Biotech
Tue, 09/13/22 - 10:40 am
Akero Therapeuticsw
NASH
liver fibrosis
clinical trials
efruxifermin
Preclinical Data Shows Potential Path to Reverse Type-2 Diabetes and Liver Fibrosis
BioSpace
Tue, 02/11/20 - 10:41 am
Yale
type 2 diabetes
liver fibrosis
NASH-linked gene discovery could inspire new drugs to treat liver damage
Fierce Biotech
Fri, 07/19/19 - 12:50 pm
NASH
R&D
drug development
genetics
liver damage
liver fibrosis